StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2014, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 17 Feb 2010 11:13:32 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Merriman Curhan Ford Maintains a 'Buy' on Cyclacel Pharmaceuticals (CYCC); Raises PT Range http://www.streetinsider.com/Analyst+Comments/Merriman+Curhan+Ford+Maintains+a+%27Buy%27+on+Cyclacel+Pharmaceuticals+%28CYCC%29%3B+Raises+PT+Range/5357196.html Visit StreetInsider.com at http://www.streetinsider.com/Analyst+Comments/Merriman+Curhan+Ford+Maintains+a+%27Buy%27+on+Cyclacel+Pharmaceuticals+%28CYCC%29%3B+Raises+PT+Range/5357196.html for the full story. http://www.streetinsider.com/Analyst+Comments/Merriman+Curhan+Ford+Maintains+a+%27Buy%27+on+Cyclacel+Pharmaceuticals+%28CYCC%29%3B+Raises+PT+Range/5357196.html Wed, 17 Feb 2010 11:13:32 -0500 CYCC CYCC GENZ GENZ JNJ JNJ VION Merriman Curhan Ford Maintains a 'Buy' on Cyclacel Pharmaceuticals (CYCC); Raises PT Range http://www.streetinsider.com/Analyst+Comments/Merriman+Curhan+Ford+Maintains+a+%27Buy%27+on+Cyclacel+Pharmaceuticals+%28CYCC%29%3B+Raises+PT+Range/5357196.html Visit StreetInsider.com at http://www.streetinsider.com/Analyst+Comments/Merriman+Curhan+Ford+Maintains+a+%27Buy%27+on+Cyclacel+Pharmaceuticals+%28CYCC%29%3B+Raises+PT+Range/5357196.html for the full story. http://www.streetinsider.com/Analyst+Comments/Merriman+Curhan+Ford+Maintains+a+%27Buy%27+on+Cyclacel+Pharmaceuticals+%28CYCC%29%3B+Raises+PT+Range/5357196.html Wed, 17 Feb 2010 11:13:32 -0500 CYCC CYCC GENZ GENZ JNJ JNJ VION Merriman Curhan Ford Maintains a 'Buy' on Cyclacel Pharmaceuticals (CYCC); Raises PT Range http://www.streetinsider.com/Analyst+Comments/Merriman+Curhan+Ford+Maintains+a+%27Buy%27+on+Cyclacel+Pharmaceuticals+%28CYCC%29%3B+Raises+PT+Range/5357196.html Visit StreetInsider.com at http://www.streetinsider.com/Analyst+Comments/Merriman+Curhan+Ford+Maintains+a+%27Buy%27+on+Cyclacel+Pharmaceuticals+%28CYCC%29%3B+Raises+PT+Range/5357196.html for the full story. http://www.streetinsider.com/Analyst+Comments/Merriman+Curhan+Ford+Maintains+a+%27Buy%27+on+Cyclacel+Pharmaceuticals+%28CYCC%29%3B+Raises+PT+Range/5357196.html Wed, 17 Feb 2010 11:13:32 -0500 CYCC CYCC GENZ GENZ JNJ JNJ VION Merriman Curhan Ford Maintains a 'Buy' on Cyclacel Pharmaceuticals (CYCC); Raises PT Range http://www.streetinsider.com/Analyst+Comments/Merriman+Curhan+Ford+Maintains+a+%27Buy%27+on+Cyclacel+Pharmaceuticals+%28CYCC%29%3B+Raises+PT+Range/5357196.html Visit StreetInsider.com at http://www.streetinsider.com/Analyst+Comments/Merriman+Curhan+Ford+Maintains+a+%27Buy%27+on+Cyclacel+Pharmaceuticals+%28CYCC%29%3B+Raises+PT+Range/5357196.html for the full story. http://www.streetinsider.com/Analyst+Comments/Merriman+Curhan+Ford+Maintains+a+%27Buy%27+on+Cyclacel+Pharmaceuticals+%28CYCC%29%3B+Raises+PT+Range/5357196.html Wed, 17 Feb 2010 11:13:32 -0500 CYCC CYCC GENZ GENZ JNJ JNJ VION Merriman Curhan Ford Maintains a 'Buy' on Cyclacel Pharmaceuticals (CYCC); Raises PT Range http://www.streetinsider.com/Analyst+Comments/Merriman+Curhan+Ford+Maintains+a+%27Buy%27+on+Cyclacel+Pharmaceuticals+%28CYCC%29%3B+Raises+PT+Range/5357196.html Visit StreetInsider.com at http://www.streetinsider.com/Analyst+Comments/Merriman+Curhan+Ford+Maintains+a+%27Buy%27+on+Cyclacel+Pharmaceuticals+%28CYCC%29%3B+Raises+PT+Range/5357196.html for the full story. http://www.streetinsider.com/Analyst+Comments/Merriman+Curhan+Ford+Maintains+a+%27Buy%27+on+Cyclacel+Pharmaceuticals+%28CYCC%29%3B+Raises+PT+Range/5357196.html Wed, 17 Feb 2010 11:13:32 -0500 CYCC CYCC GENZ GENZ JNJ JNJ VION Merriman Curhan Ford Maintains a 'Buy' on Cyclacel Pharmaceuticals (CYCC); Raises PT Range http://www.streetinsider.com/Analyst+Comments/Merriman+Curhan+Ford+Maintains+a+%27Buy%27+on+Cyclacel+Pharmaceuticals+%28CYCC%29%3B+Raises+PT+Range/5357196.html Visit StreetInsider.com at http://www.streetinsider.com/Analyst+Comments/Merriman+Curhan+Ford+Maintains+a+%27Buy%27+on+Cyclacel+Pharmaceuticals+%28CYCC%29%3B+Raises+PT+Range/5357196.html for the full story. http://www.streetinsider.com/Analyst+Comments/Merriman+Curhan+Ford+Maintains+a+%27Buy%27+on+Cyclacel+Pharmaceuticals+%28CYCC%29%3B+Raises+PT+Range/5357196.html Wed, 17 Feb 2010 11:13:32 -0500 CYCC CYCC GENZ GENZ JNJ JNJ VION Merriman Curhan Ford Maintains a 'Buy' on Cyclacel Pharmaceuticals (CYCC); Raises PT Range http://www.streetinsider.com/Analyst+Comments/Merriman+Curhan+Ford+Maintains+a+%27Buy%27+on+Cyclacel+Pharmaceuticals+%28CYCC%29%3B+Raises+PT+Range/5357196.html Visit StreetInsider.com at http://www.streetinsider.com/Analyst+Comments/Merriman+Curhan+Ford+Maintains+a+%27Buy%27+on+Cyclacel+Pharmaceuticals+%28CYCC%29%3B+Raises+PT+Range/5357196.html for the full story. http://www.streetinsider.com/Analyst+Comments/Merriman+Curhan+Ford+Maintains+a+%27Buy%27+on+Cyclacel+Pharmaceuticals+%28CYCC%29%3B+Raises+PT+Range/5357196.html Wed, 17 Feb 2010 11:13:32 -0500 CYCC CYCC GENZ GENZ JNJ JNJ VION U.S. FDA Responds to VION Pharma's (VION) HOVON AML 92 Phase III Evaluation http://www.streetinsider.com/Corporate+News/U.S.+FDA+Responds+to+VION+Pharma%27s+%28VION%29+HOVON+AML+92+Phase+III+Evaluation/5210835.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/U.S.+FDA+Responds+to+VION+Pharma%27s+%28VION%29+HOVON+AML+92+Phase+III+Evaluation/5210835.html for the full story. http://www.streetinsider.com/Corporate+News/U.S.+FDA+Responds+to+VION+Pharma%27s+%28VION%29+HOVON+AML+92+Phase+III+Evaluation/5210835.html Wed, 30 Dec 2009 08:06:15 -0500 VION U.S. FDA Responds to VION Pharma's (VION) HOVON AML 92 Phase III Evaluation http://www.streetinsider.com/FDA/U.S.+FDA+Responds+to+VION+Pharma%27s+%28VION%29+HOVON+AML+92+Phase+III+Evaluation/5210835.html Visit StreetInsider.com at http://www.streetinsider.com/FDA/U.S.+FDA+Responds+to+VION+Pharma%27s+%28VION%29+HOVON+AML+92+Phase+III+Evaluation/5210835.html for the full story. http://www.streetinsider.com/FDA/U.S.+FDA+Responds+to+VION+Pharma%27s+%28VION%29+HOVON+AML+92+Phase+III+Evaluation/5210835.html Wed, 30 Dec 2009 08:06:15 -0500 VION Vion Pharma (VION) Files for Chapter 11 Bankruptcy http://www.streetinsider.com/Corporate+News/Vion+Pharma+%28VION%29+Files+for+Chapter+11+Bankruptcy/5193644.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Vion+Pharma+%28VION%29+Files+for+Chapter+11+Bankruptcy/5193644.html for the full story. http://www.streetinsider.com/Corporate+News/Vion+Pharma+%28VION%29+Files+for+Chapter+11+Bankruptcy/5193644.html Thu, 17 Dec 2009 15:37:32 -0500 VION Vion Pharma (VION) Files for Chapter 11 Bankruptcy http://www.streetinsider.com/Guidance/Vion+Pharma+%28VION%29+Files+for+Chapter+11+Bankruptcy/5193644.html Visit StreetInsider.com at http://www.streetinsider.com/Guidance/Vion+Pharma+%28VION%29+Files+for+Chapter+11+Bankruptcy/5193644.html for the full story. http://www.streetinsider.com/Guidance/Vion+Pharma+%28VION%29+Files+for+Chapter+11+Bankruptcy/5193644.html Thu, 17 Dec 2009 15:37:32 -0500 VION Vion Pharma (VION) Hires Merriman Curhan Ford to Evaluate Strategic Alternatives http://www.streetinsider.com/Corporate+News/Vion+Pharma+%28VION%29+Hires+Merriman+Curhan+Ford+to+Evaluate+Strategic+Alternatives/5010276.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Vion+Pharma+%28VION%29+Hires+Merriman+Curhan+Ford+to+Evaluate+Strategic+Alternatives/5010276.html for the full story. http://www.streetinsider.com/Corporate+News/Vion+Pharma+%28VION%29+Hires+Merriman+Curhan+Ford+to+Evaluate+Strategic+Alternatives/5010276.html Mon, 12 Oct 2009 16:02:29 -0500 VION Vion Pharmaceuticals (VION) Submits New Drug Application for Onrigin http://www.streetinsider.com/FDA/Vion+Pharmaceuticals+%28VION%29+Submits+New+Drug+Application+for+Onrigin/4404372.html Visit StreetInsider.com at http://www.streetinsider.com/FDA/Vion+Pharmaceuticals+%28VION%29+Submits+New+Drug+Application+for+Onrigin/4404372.html for the full story. http://www.streetinsider.com/FDA/Vion+Pharmaceuticals+%28VION%29+Submits+New+Drug+Application+for+Onrigin/4404372.html Tue, 17 Feb 2009 08:42:04 -0500 VION VION Pharmaceuticals (VION) Reports Interim Data on Phase II Trial of Cloretazine http://www.streetinsider.com/Corporate+News/VION+Pharmaceuticals+%28VION%29+Reports+Interim+Data+on+Phase+II+Trial+of+Cloretazine/3705790.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/VION+Pharmaceuticals+%28VION%29+Reports+Interim+Data+on+Phase+II+Trial+of+Cloretazine/3705790.html for the full story. http://www.streetinsider.com/Corporate+News/VION+Pharmaceuticals+%28VION%29+Reports+Interim+Data+on+Phase+II+Trial+of+Cloretazine/3705790.html Mon, 02 Jun 2008 15:13:01 -0500 VION Vion Pharmaceuticals (VION) Reports a Q1 Loss http://www.streetinsider.com/Earnings/Vion+Pharmaceuticals+%28VION%29+Reports+a+Q1+Loss/3609858.html Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Vion+Pharmaceuticals+%28VION%29+Reports+a+Q1+Loss/3609858.html for the full story. http://www.streetinsider.com/Earnings/Vion+Pharmaceuticals+%28VION%29+Reports+a+Q1+Loss/3609858.html Mon, 05 May 2008 16:40:07 -0500 VION Vion Pharmaceuticals (VION) Reports a Q1 Loss http://www.streetinsider.com/FDA/Vion+Pharmaceuticals+%28VION%29+Reports+a+Q1+Loss/3609858.html Visit StreetInsider.com at http://www.streetinsider.com/FDA/Vion+Pharmaceuticals+%28VION%29+Reports+a+Q1+Loss/3609858.html for the full story. http://www.streetinsider.com/FDA/Vion+Pharmaceuticals+%28VION%29+Reports+a+Q1+Loss/3609858.html Mon, 05 May 2008 16:40:07 -0500 VION VION (VION) Said FDA Lifts Clinical Hold on Phase III Study of Cloretazine http://www.streetinsider.com/FDA/VION+%28VION%29+Said+FDA+Lifts+Clinical+Hold+on+Phase+III+Study+of+Cloretazine/3248336.html Visit StreetInsider.com at http://www.streetinsider.com/FDA/VION+%28VION%29+Said+FDA+Lifts+Clinical+Hold+on+Phase+III+Study+of+Cloretazine/3248336.html for the full story. http://www.streetinsider.com/FDA/VION+%28VION%29+Said+FDA+Lifts+Clinical+Hold+on+Phase+III+Study+of+Cloretazine/3248336.html Tue, 08 Jan 2008 08:17:13 -0500 VION Vion Pharmaceuticals (VION) Presents Updated Clinical Data from a Phase II Trial of Cloretazine http://www.streetinsider.com/FDA/Vion+Pharmaceuticals+%28VION%29+Presents+Updated+Clinical+Data+from+a+Phase+II+Trial+of+Cloretazine/2408772.html Visit StreetInsider.com at http://www.streetinsider.com/FDA/Vion+Pharmaceuticals+%28VION%29+Presents+Updated+Clinical+Data+from+a+Phase+II+Trial+of+Cloretazine/2408772.html for the full story. http://www.streetinsider.com/FDA/Vion+Pharmaceuticals+%28VION%29+Presents+Updated+Clinical+Data+from+a+Phase+II+Trial+of+Cloretazine/2408772.html Mon, 04 Jun 2007 08:29:49 -0500 VION Rodman & Renshaw downgrades Vion Pharmaceuticals (VION) to Market Perform http://www.streetinsider.com/Downgrades/Rodman+%26+Renshaw+downgrades+Vion+Pharmaceuticals+%28VION%29+to+Market+Perform/2349218.html Visit StreetInsider.com at http://www.streetinsider.com/Downgrades/Rodman+%26+Renshaw+downgrades+Vion+Pharmaceuticals+%28VION%29+to+Market+Perform/2349218.html for the full story. http://www.streetinsider.com/Downgrades/Rodman+%26+Renshaw+downgrades+Vion+Pharmaceuticals+%28VION%29+to+Market+Perform/2349218.html Thu, 24 May 2007 09:49:56 -0500 VION